Core commitments for field trials of gene drive organismsKanya C. Long, Omar S. Akbari, Chun‐Hong Chen et al.|Science|2020Cited by 109
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trialKarin Hardt, Jeffrey J. Stoddard, An Vandebosch et al.|The Lancet Infectious Diseases|2022Cited by 88
Evolutionary loss of foot muscle during development with characteristics of atrophy and no evidence of cell deathMai P. Tran, Kimberly L. Cooper|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 0